Literature DB >> 8036821

OmpA-FMDV VP1 fusion proteins: production, cell surface exposure and immune responses to the major antigenic domain of foot-and-mouth disease virus.

A Ruppert1, N Arnold, G Hobom.   

Abstract

Exposure at the bacterial outer surface of the major antigenic epitope of the foot-and-mouth disease (FMDV) viral protein VP1 was studied using protein fusion with outer membrane protein A (OmpA) of Shigella dysenteriae for production and transport of the foreign polypeptide to the outer membrane of Escherichia coli. Fusion constructs with VP1 peptide insertions of up to 56 amino acids in the third outer domain of OmpA could be demonstrated on the bacterial surface by indirect immunofluorescence and immunogold labelling. OmpA fusion proteins with large insertions from sequences of the FMDV protein VP1 were shown to elicit virus-specific immune responses in rabbits.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8036821     DOI: 10.1016/0264-410x(94)90305-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  An alternative topological model for Escherichia coli OmpA.

Authors:  C Stathopoulos
Journal:  Protein Sci       Date:  1996-01       Impact factor: 6.725

2.  Characterization of Escherichia coli expressing an Lpp'OmpA(46-159)-PhoA fusion protein localized in the outer membrane.

Authors:  C Stathopoulos; G Georgiou; C F Earhart
Journal:  Appl Microbiol Biotechnol       Date:  1996-03       Impact factor: 4.813

3.  Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7.

Authors:  Kun Cai; Wei Tu; Yuenan Liu; Tao Li; Hui Wang
Journal:  Sci Rep       Date:  2015-12-02       Impact factor: 4.379

4.  Differential bacterial surface display of peptides by the transmembrane domain of OmpA.

Authors:  Gertjan S Verhoeven; Svetlana Alexeeva; Marileen Dogterom; Tanneke den Blaauwen
Journal:  PLoS One       Date:  2009-08-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.